Philip B. Emmerich
-
- Cancer Cells and Metastasis 7
- Cancer Immunotherapy and Biomarkers 6
-
- Cancer, Hypoxia, and Metabolism 3
-
- Immunotherapy and Immune Responses 5
- Immune cells in cancer 4
-
- Cancer Research and Treatments 4
-
- Glycosylation and Glycoproteins Research 3
-
- Proteoglycans and glycosaminoglycans research 3
- Co-authors
- Manuel BaumannMarcel WeilDustin A. DemingKristina A. MatkowskyjLinda ClipsonChelsea HopeAdam PagenkopfAthanasios Papadas
- Partner nations
- United StatesGermany
In The Last Decade
Philip B. Emmerich
18 papers receiving 324 citations
Peers
Comparison fields: 5 of 78
- Energy Engineering and Power Technology 25
- Pollution 64
- Oncology 117
- Cancer Research 52
- Management, Monitoring, Policy and Law 37
Countries citing papers authored by Philip B. Emmerich
This map shows the geographic impact of Philip B. Emmerich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip B. Emmerich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip B. Emmerich more than expected).
Fields of papers citing papers by Philip B. Emmerich
This network shows the impact of papers produced by Philip B. Emmerich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip B. Emmerich. The network helps show where Philip B. Emmerich may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philip B. Emmerich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 1 | |
| 5 | 2022 | 21 | |
| 6 | 2022 | 61 | |
| 7 | 2022 | 2 | |
| 8 | 2020 | 7 | |
| 9 | 2020 | 7 | |
| 10 | 2020 | 80 | |
| 11 | 2020 | 4 | |
| 12 | 2020 | 2 | |
| 13 | 2020 | 1 | |
| 14 | 2020 | 2 | |
| 15 | 2019 | 23 | |
| 16 | 2019 | 2 | |
| 17 | 2019 | 15 | |
| 18 | 2019 | 2 | |
| 19 | 2017 | 1 | |
| 20 | 2017 | 89 |
About Philip B. Emmerich
Philip B. Emmerich is a scholar working on Oncology, Biotechnology and Cancer Research, having authored 21 papers that have together received 330 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (5 papers), Cancer Research and Treatments (4 papers), Immune cells in cancer (4 papers), Glycosylation and Glycoproteins Research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Proteoglycans and glycosaminoglycans research (3 papers). The work is most often cited by research in Energy Engineering and Power Technology (25 citations), Pollution (64 citations) and Oncology (117 citations). Philip B. Emmerich has collaborated with scholars based in United States and Germany. Frequent co-authors include Manuel Baumann, Marcel Weil, Dustin A. Deming, Kristina A. Matkowskyj, Linda Clipson, Chelsea Hope, Adam Pagenkopf, Athanasios Papadas, Fotis Asimakopoulos and Rebecca A. DeStefanis. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.